{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:55:28Z","timestamp":1776873328708,"version":"3.51.2"},"reference-count":20,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0971-4065.107215","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T12:24:28Z","timestamp":1360931068000},"page":"67","source":"Crossref","is-referenced-by-count":12,"title":["Sunitinib induced nephrotic syndrome and thrombotic microangiopathy"],"prefix":"10.25259","volume":"23","author":[{"given":"M","family":"Vankalakunti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PK","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Siddini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bonu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GK","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HS","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.107215-1","first-page":"1329","volume-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: A randomised controlled trial","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"key-10.4103\/0971-4065.107215-2","first-page":"2103","volume-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: A randomised, double-blind phase III trial","author":"Escudier","year":"2007","journal-title":"Lancet"},{"key":"key-10.4103\/0971-4065.107215-3","first-page":"2335","volume-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.107215-4","first-page":"2666","volume-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.107215-5","first-page":"115","volume-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.107215-6","first-page":"5422","volume-title":"Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206","author":"Rini","year":"2008","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0971-4065.107215-7","first-page":"2542","volume-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.107215-8","first-page":"282","volume-title":"A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","author":"Patel","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0971-4065.107215-9","first-page":"1049","volume-title":"A case of membranous glomerulonephritis associated with adenocarcinoma of pancreas","author":"Helin","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.107215-10","first-page":"25130","volume-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","author":"He","year":"1999","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0971-4065.107215-11","first-page":"2293","volume-title":"Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?","author":"Boner","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.107215-12","first-page":"95","volume-title":"Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis","author":"Fan","year":"2002","journal-title":"Nephron"},{"key":"key-10.4103\/0971-4065.107215-13","first-page":"176973","volume-title":"Renal involvement in preeclampsia: Similarities to VEGF ablation therapy","author":"Muller-Deile","year":"2011","journal-title":"J Pregnancy"},{"key":"key-10.4103\/0971-4065.107215-14","first-page":"1129","volume-title":"VEGF inhibition and renal thrombotic microangiopathy","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.107215-15","first-page":"1745","volume-title":"Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome","author":"Kapiteijn","year":"2007","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0971-4065.107215-16","first-page":"682","volume-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","author":"Bollee","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.107215-17","first-page":"172","volume-title":"Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib","author":"Chen","year":"2009","journal-title":"Case Rep Oncol"},{"key":"key-10.4103\/0971-4065.107215-18","first-page":"1001","volume-title":"Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy","author":"Costero","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.107215-19","first-page":"673","volume-title":"Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: A class effect?","author":"Winn","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.107215-20","first-page":"177","volume-title":"Renal thrombotic microangiopathy caused by anti-VEG-Fantibody treatment for metastatic renal-cell carcinoma","author":"Frangie","year":"2007","journal-title":"Lancet Oncol"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:36:36Z","timestamp":1712172996000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/sunitinib-induced-nephrotic-syndrome-and-thrombotic-microangiopathy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["107215"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.107215","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}